Skip to main content
Premium Trial:

Request an Annual Quote

Caliper s Q2 Revenues Up 7.5 Percent, Loss Narrows by More than Half

NEW YORK, July 28 (GenomeWeb News) - Caliper Life Sciences yesterday reported an uptick in revenues and narrowed losses for the second quarter of 2004.

 

Total revenues for the quarter were $20.3 million, up 7.5 percent from $18.9 million in the same period last year. Revenue from licensing fees and contracts almost doubled, to $4.3 million from $2.4 million during the year-ago quarter.

 

Research and development costs declined to $4.5 million, from $6.6 million during the year-ago quarter.

 

Caliper's net loss totaled $4.2 million, or $.14 per share, down from $9.5 million, or $.33 per share, in the second quarter of 2004.

 

As of June 30, Caliper had $5.1 million in cash and cash equivalents, and $35.7 million in marketable securities.